Clostridium niakharense sp. nov., a novel species isolated from the breast milk of a Senegalese mother breastfeeding a healthy child

The human body is not a solitary vessel but a bustling ecosystem, teeming with microscopic life that inhabits every surface and opening. Among these communities, the bacteria found in breast milk have long been a subject of fascination for scientists, as this fluid is the first food for infants and a critical source of early microbial colonization. For decades, researchers believed that the bacteria in milk were mostly harmless passengers or, in some cases, contaminants from the environment. However, the tools used to study these tiny organisms have evolved. Scientists can now grow bacteria that were previously thought to be impossible to culture in a lab, allowing them to see the actual living cells rather than just inferring their presence from genetic fragments. This shift has opened a new window into the diversity of life that exists within the human body, revealing species that have never been seen before and challenging old assumptions about where these microbes come from and what they do.

In a recent study, researchers uncovered a new species of bacteria living in the breast milk of a healthy mother in Senegal. The team, working from laboratories in France and Senegal, collected milk samples from a mother breastfeeding a healthy child in the Niakhar region. They used a specialized technique called culturomics, which involves growing bacteria in a variety of conditions to coax even the most difficult-to-catch microbes into growing. From this effort, they isolated a single strain of bacteria, which they named Marseille-QA1073. At first glance, this bacterium looked like a known type. Under a microscope, it appeared as a curved, spindle-shaped rod that could move on its own and form tough, dormant spores to survive harsh conditions. It was a Gram-positive bacterium, meaning it had a thick cell wall that stained purple in a standard test, and it thrived only in environments without oxygen.

When the scientists first tried to identify the bacteria using standard protein fingerprinting, the machine could not match it to any known species. They then turned to a more powerful method: reading the bacterium's entire genetic code. By comparing the genetic sequence of the new strain to a database of known bacteria, they found it was most similar to two existing species, Clostridium argentinense and Clostridium faecium. The genetic similarity was so high—about 99 percent—that the standard genetic marker used for identification could not tell them apart. In the past, this might have been enough to classify the new strain as one of those known species. However, the researchers knew that looking at a single gene was not enough to make a definitive call. They needed to look at the entire genome, the complete set of instructions that makes up the organism.

When they compared the full genetic blueprint of the new strain to its closest relatives, the differences became clear. The new bacterium shared only about 94 percent of its genetic material with Clostridium argentinense and about 87 percent with Clostridium faecium. In the world of bacterial taxonomy, these numbers are the deciding factor. To be considered the same species, two bacteria must share at least 95 percent of their genetic identity. Because the new strain fell well below this threshold, the researchers concluded that it was not a known species but something entirely new. They proposed the name Clostridium niakharense, a nod to the Niakhar region where the sample was collected.

The discovery was particularly significant because of where the bacterium was found. Many bacteria in the Clostridium family are known to live in soil and can sometimes be dangerous pathogens, producing toxins that cause serious illness. The closest relative to this new species, Clostridium argentinense, was historically associated with a type of botulism toxin. This raised an immediate question: was this new bacterium dangerous? The researchers scanned the entire genome for any genes that produce toxins or virulence factors. They found none. The new strain did not carry the genes for botulinum neurotoxin or any other known harmful agents. It was a safe, non-toxic member of a family that often includes dangerous relatives.

The study also revealed how this bacterium resists certain antibiotics. The genome showed that the bacterium carries a specific set of genes on its main chromosome that allow it to withstand vancomycin, a powerful antibiotic often used as a last resort. This resistance was confirmed in the lab, where the bacterium grew in the presence of the drug. However, it remained sensitive to teicoplanin, a related antibiotic, a pattern that is typical for this specific type of genetic resistance. The researchers noted that the bacterium also showed resistance to other common antibiotics, but this appeared to be a natural trait of the group rather than a newly acquired superpower.

Perhaps the most intriguing aspect of the finding was the bacterium's likely origin. While it was found in human milk, the researchers used computer models to predict where this type of bacteria usually lives. The models suggested that the bacterium is primarily an inhabitant of soil and the rhizosphere, the area of soil surrounding plant roots. This implies that the bacterium found in the breast milk was likely not a permanent resident of the human body but rather a transient visitor. It probably arrived in the milk through environmental exposure, such as the mother handling soil or plants, and survived the journey because it can form tough spores. This aligns with the behavior of many bacteria in this family, which are widespread in the environment and can occasionally be found in humans without causing harm.

The successful isolation of this bacterium highlights the value of using advanced culturing techniques to explore the human microbiome. Many bacteria are slow-growing or have specific needs that standard lab methods miss. By using prolonged incubation and specialized growth media, the team was able to bring this fastidious organism to life. This discovery adds a new entry to the growing list of bacterial species found in human milk and expands our understanding of the microbial diversity that surrounds us. It serves as a reminder that even in the most familiar settings, like a mother's breast milk, there are still unknown forms of life waiting to be discovered, and that these new discoveries often come with reassurances about safety rather than warnings of danger. The strain has been preserved in culture collections for future study, ensuring that this newly named species, Clostridium niakharense, will be available for scientists to learn from for years to come.